Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $3,000,000
- Closes
- Sep 30, 2026 (in 62 days)
Similar opportunities open now
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)OpenNational Institutes of HealthCloses Aug 2028Up to $3M
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2026Up to $750K
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)OpenNational Institutes of HealthCloses in 39 days
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)OpenNational Institutes of HealthCloses Oct 2027
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)OpenNational Institutes of HealthCloses Aug 2027Up to $150K
Classification and identifiers
- Solicitation number
- RFA-DA-27-015
- Assistance listing (CFDA)
- 93.279
Amount
$3,000,000
Who can apply
Private colleges and universities, Public colleges and universities, and Nonprofits, including small and volunteer-run organizations can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
About this opportunity
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.
Related opportunities
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)National Institutes of HealthCloses Aug 2028Up to $3M
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)National Institutes of HealthCloses Nov 2026Up to $750K
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)National Institutes of HealthCloses in 39 days